Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2021.12.23

Watch Dr. M. Damodharan from Sai Life Sciences presenting on the topic 'Regulatory Compliance through Instrument Integration and Scientific Data Management'

Watch Dr. M. Damodharan from Sai Life Sciences presenting on the topic 'Regulatory Compliance through Instrument Integration and Scientific Data Management'

Dr. M. Damodharan, Chief Quality Officer at Sai Life Sciences participated in a webinar, presenting on the topic Regulatory Compliance through Instrument Integration and Scientific Data Management, organized by the International Society for Pharmaceutical Engineering  (ISPE), India.

The webinar titled ‘Regulatory Compliance through Instrument Integration and Scientific Data Management’ is part of the ongoing ‘Pharma Best Practices Webinars’ initiative by ISPE where each webinar features leading subject matter experts covering critical, relevant topics in pharmaceutical manufacturing.

In this webinar, Dr. M. Damodharan presented on the industry-first solution deployed successfully and their benefits in handling instrument integration, data storage, and archival functions and heading towards the fully paperless lab.

Key regulatory requirements and expectations addressed in the presentation:

1. Effective instrument integration in real-time from all types of instruments and all types of file and data formats.

2. Secure storage of the raw data and processed data at the time they are produced,

3. Secure storage and archival of the data for both internal and external audit purposes SDMS- Scientific data management system is the potential solution beyond LIMS, ELN, CDS, and Manual data storage and archival.

As per ISPE, over 1300+ delegate registrations were recorded for this event, which was broadcast live by ISPE on YouTube.

Watch the full video

https://www.youtube.com/watch?v=WfHPriSFKXQ
Share article

More News

2025.09.05

Reviving Kudikunta Lake: Bringing nature and community closer together

As part of its Corporate Social Responsibility initiative, Sai Life Sciences has taken up the development of Kudikunta Lake in Hyderabad, reinforcing its commitment to sustainability and community well-being. The Kudikunta Lake initiative marks a significant step in restoring one of Hyderabad’s key lakes and advancing the cause of sustainable urban living. The company has […]
Read more

2025.09.05

From injections to pills: oral peptides set to transform drug development

In a recent article published in Drug Target Review, Dr Santosh Kulkarni highlights the shift from injections to pills. He writes about how oral peptide therapeutics are overcoming the long-standing challenge of poor bioavailability—bringing us closer to patient-friendly medicines without compromising efficacy. The article highlights the booming peptide drug market and the scientific advances—from chemical […]
Read more

2025.08.28

Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new Production Block (PB-11) at the company’s flagship API manufacturing facility in Bidar, India (Unit IV). The Phase I of PB-11, with a capacity of 110 KL, was inaugurated […]
Read more

2025.08.20

Sai Life Sciences secures SBTi validation for near-term climate targets

Sai Life Sciences Limited, an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse gas (GHG) emissions have been validated by the Science Based Targets initiative (SBTi)—a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. […]
Read more

2025.08.20

Sai Life Sciences featured in Drug Discovery & Development on trends shaping drug discovery

Sai Life Sciences was recently featured in Drug Discovery & Development, where Dr Maneesh Pingle, Executive Vice President and Head of Discovery Services, shared insights on the emerging trends in pharma sector. A key focus was the impact of GLP 1 agonists in accelerating peptide drug discovery. Dr. Pingle explained how the success of these […]
Read more